Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

This study is ongoing, but not recruiting participants.

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00185887

Purpose

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Condition	Intervention
Fetal Distress	Drug: nitroglycerin and terbutaline

Drug Information available for: Nitroglycerin Terbutaline Terbutaline sulfate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment
Official Title:	Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Further study details as provided by Stanford University:

Primary Outcome Measures:

resolution of abnormal fetal heart tracing

Secondary Outcome Measures:

cesarean section rate
operative vaginal delivery rate
neonatal outcomes

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria::

nonreassuring fetal heart rate tracing
 Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00185887

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

Yasser Yehia El-Sayed

Stanford University

More Information

American Journal of Obstetrics and Gynecology. 2007 Oct;197(4):414.el-6 This link exits the ClinicalTrials.gov site

Study ID Numbers:	79504
Study First Received:	September 12, 2005
Last Updated:	November 19, 2008
ClinicalTrials.gov Identifier:	NCT00185887
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Nitroglycerin
Signs and Symptoms
Fetal Distress
Terbutaline

Additional relevant MeSH terms:

Respiratory System Agents
Neurotransmitter Agents
Vasodilator Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic beta-Agonists
Sympathomimetics
Physiological Effects of Drugs
Anti-Asthmatic Agents

Cardiovascular Agents
Reproductive Control Agents
Adrenergic Agonists
Pharmacologic Actions
Tocolytic Agents
Autonomic Agents
Therapeutic Uses
Peripheral Nervous System Agents
Bronchodilator Agents

ClinicalTrials.gov processed this record on January 14, 2009